VIP Improves Intestinal Barrier Homeostasis in Inflammatory Bowel Diseases like Crohns’ and Ulcerative Colitis
Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis (6): “Attaching and effacing bacterial pathogens attach to the apical surface of epithelial cells and disrupt epithelial barrier function, increasing permeability and allowing luminal contents access to the underlying milieu. Previous in vitro studies demonstrated that the neuropeptide vasoactive intestinal peptide (VIP) re
1 min read
Read More